UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance

Drug resistance updates, 2011-04, Vol.14 (2), p.77-78

Bergström, Richard

2011

Volltextzugriff (PDF)

Drug pollution: Europe responds

Nature (London), 2015-11, Vol.527 (7577), p.165-165

2015

Volltextzugriff (PDF)

Antibiotic resistance—the need for global solutions

The Lancet infectious diseases, 2013-12, Vol.13 (12), p.1057-1098

2013

Volltextzugriff (PDF)

Priorities for improving drug research, development and regulation

Nature reviews. Drug discovery, 2013-04, Vol.12 (4), p.247-248

2013

Volltextzugriff (PDF)

IMI moves forward

Nature biotechnology, 2011-08, Vol.29 (8), p.689-690

2011

Volltextzugriff (PDF)

Increased momentum in antimicrobial resistance research

The Lancet (British edition), 2016-08, Vol.388 (10047), p.865-865

2016

Volltextzugriff (PDF)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Clinical and translational science, 2019-09, Vol.12 (5), p.519-528

2019

Volltextzugriff (PDF)

Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia

The American journal of psychiatry, 2010-02, Vol.167 (2), p.181-189

2010

Volltextzugriff (PDF)

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective

International clinical psychopharmacology, 2014-11, Vol.29 (6), p.299-312

2014

Volltextzugriff (PDF)

Preoperative anemia and transfusion in cardiac surgery: a single-centre retrospective study

Journal of cardiothoracic surgery, 2021-04, Vol.16 (1), p.109-109, Article 109

2021

Volltextzugriff (PDF)

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

BMC psychiatry, 2010-06, Vol.10 (1), p.45-45, Article 45

2010

Volltextzugriff (PDF)

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Clinical and translational science, 2021-09, Vol.14 (5), p.1864-1874

2021

Volltextzugriff (PDF)

Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On‐Demand HIV Preexposure Prophylaxis

Clinical pharmacology and therapeutics, 2020-05, Vol.107 (5), p.1200-1208

2020

Volltextzugriff (PDF)

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

Clinical pharmacokinetics, 2008-01, Vol.47 (3), p.191-202

2008

Volltextzugriff (PDF)

Role for Postoperative Radiation Therapy in Adenoid Cystic Carcinoma of the Head and Neck

The Laryngoscope, 2004-07, Vol.114 (7), p.1194-1199

2004

Volltextzugriff (PDF)

Richard Bergström. Interview by Asher Mullard

Nature reviews. Drug discovery, 2011-06, Vol.10 (6), p.408

Bergström, Richard

2011

Volltextzugriff (PDF)

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration

Journal of clinical psychopharmacology, 2009-06, Vol.29 (3), p.278-283

2009

Volltextzugriff (PDF)

Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study

Diabetes care, 1999-11, Vol.22 (11), p.1808-1812

1999

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Clinical therapeutics, 2013-12, Vol.35 (12), p.1890-1908

2013

Volltextzugriff (PDF)

The patent is "engine" in drug development

Läkartidningen, 2008-03, Vol.105 (10), p.752-752

Bergström, Richard

2008

Volltextzugriff (PDF)

The industry recommends increased use. Biosimilars are like generics, but still not

Läkartidningen, 2010-10, Vol.107 (42), p.2584-2585

2010

Volltextzugriff (PDF)

Drivers of the cost of cancer care

The lancet oncology, 2012, Vol.13 (1), p.14-15

Bergstrom, Richard

2012

Volltextzugriff (PDF)

Duloxetine: Clinical Pharmacokinetics and Drug Interactions

Clinical pharmacokinetics, 2011-05, Vol.50 (5), p.281-294

2011

Volltextzugriff (PDF)

Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women

Clinical pharmacokinetics, 2008-01, Vol.47 (2), p.103-109

2008

Volltextzugriff (PDF)

The journals must honestly tell who is doing the job

Läkartidningen, 2008-05, Vol.105 (19), p.1406-1407

Bergström, Richard

2008

Volltextzugriff (PDF)

1 – 25 von 485

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(412)
Mit Volltextzugriff
(399)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance

Drug pollution: Europe responds

Antibiotic resistance—the need for global solutions

Priorities for improving drug research, development and regulation

IMI moves forward

Increased momentum in antimicrobial resistance research

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective

Preoperative anemia and transfusion in cardiac surgery: a single-centre retrospective study

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On‐Demand HIV Preexposure Prophylaxis

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

Role for Postoperative Radiation Therapy in Adenoid Cystic Carcinoma of the Head and Neck

Richard Bergström. Interview by Asher Mullard

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration

Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

The patent is "engine" in drug development

The industry recommends increased use. Biosimilars are like generics, but still not

Drivers of the cost of cancer care

Duloxetine: Clinical Pharmacokinetics and Drug Interactions

Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women

The journals must honestly tell who is doing the job

Suchergebnisse filtern